Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

6-methoxy-8-hydroxylaminoquinoline

Known as: 8-HAQ cpd 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Quinolines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Primaquine-Induced Hemolytic Anemia: Susceptibility of Normal versus Glutathione-Depleted Rat Erythrocytes to 5-Hydroxyprimaquine
Primaquine is an important antimalarial agent because of its activity against exoerythrocytic forms of Plasmodium spp… Expand
  • figure 2
  • figure 4
  • figure 3
  • figure 5
  • figure 6
2002
2002
Primaquine-Induced Hemolytic Anemia: Formation of Free Radicals in Rat Erythrocytes Exposed to 6-Methoxy-8-hydroxylaminoquinoline
Primaquine is an important antimalarial drug that is often dose-limited in therapy by the onset of hemolytic anemia. We have… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2002
2002
Primaquine-Induced Hemolytic Anemia: Effect of 6-Methoxy-8-hydroxylaminoquinoline on Rat Erythrocyte Sulfhydryl Status, Membrane Lipids, Cytoskeletal Proteins, and Morphology
Previous studies have shown that 6-methoxy-8-hydroxylaminoquinoline (MAQ-NOH), anN-hydroxy metabolite of the antimalarial drug… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2001
Highly Cited
2001
Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
Primaquine is an important antimalarial agent because of its activity against exoerythrocytic forms of Plasmodium spp. However… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE